Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Amedisys Inc (NQ: AMED )

75.35 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, May 30, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 75.35
Bid (Size) 57.00 (1)
Ask (Size) 78.39 (1)
Prev. Close 75.35
Today's Range 75.35 - 75.35
52wk Range 69.36 - 131.32
Shares Outstanding 32,631,959
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Amedisys's Return On Capital Employed Overview
 
Via Benzinga
AMEDISYS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Amedisys, Inc. - AMED
From Kahn Swick & Foti, LLC
Via Business Wire

Performance

YTD
-10.16%
-10.16%
1 Month
-5.95%
-5.95%
3 Month
-18.05%
-18.05%
6 Month
-14.77%
-14.77%
1 Year
-34.99%
-34.99%

More News

Read More
Analyst Expectations for Amedisys's Future
Via Benzinga
Healthcare Giants Join Hands: Option Care Health Acquires Amedisys in a $3.6 Billion Stock Swap
Via Benzinga
AMED Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Amedisys, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Recap: Amedisys Q1 Earnings
Via Benzinga
Analyst Ratings for Amedisys
Via Benzinga
What 10 Analyst Ratings Have To Say About Amedisys
Via Benzinga
Preview: Amedisys's Earnings
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 21, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 13, 2023
Via Benzinga
Where Amedisys Stands With Analysts
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Amedisys Board of Directors Authorizes $100 Million Stock Repurchase Program
From Amedisys, Inc.
Via GlobeNewswire
Analyst Ratings for Amedisys
Via Benzinga
Expert Ratings for Amedisys
Via Benzinga
Meta Platforms To Rally 34%? Here Are 10 Other Analyst Forecasts For Thursday
Via Benzinga
Amedisys Completes Home Health Joint Venture with the University of Arkansas for Medical Sciences
From Amedisys, Inc.
Via GlobeNewswire
Amedisys is Named One of the Most Responsible Companies of 2023 by Statista and Newsweek
From Amedisys, Inc.
Via GlobeNewswire
Amedisys Names Scott Ginn Acting Chief Operating Officer
From Amedisys, Inc.
Via GlobeNewswire
Amedisys Statement on CY 2023 Home Health Final Rule
From Amedisys, Inc.
Via GlobeNewswire
Mastercard To $428? Plus This Analyst Slashes PT On Intel
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 27, 2022
Via Benzinga
Why Meta Platforms Shares Dipped Around 25%; Here Are 77 Biggest Movers From Yesterday
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.